Scarica l'app Stockscreener
3.47
7.76%
0.25
Dopo l'orario di chiusura:
3.42
-0.05
-1.44%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$3.22
Aprire:
$3.25
Volume 24 ore:
907.22K
Relative Volume:
1.73
Capitalizzazione di mercato:
$118.01M
Reddito:
$160.43M
Utile/perdita netta:
$-227.64M
Rapporto P/E:
-0.0505
EPS:
-68.77
Flusso di cassa netto:
$-170.79M
1 W Prestazione:
+11.22%
1M Prestazione:
-11.70%
6M Prestazione:
-42.83%
1 anno Prestazione:
+4.83%
Intervallo 1D:
$3.25
$3.57
Intervallo di 1 settimana:
$3.06
$3.57
Portata 52W:
$1.38
$7.34
Agenus Inc Stock (AGEN) Company Profile
Nome
Agenus Inc
Settore
Industria
Telefono
781-674-4410
Indirizzo
3 FORBES ROAD, LEXINGTON, MA
Confronta AGEN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AGEN
Agenus Inc
|
3.47 | 109.51M | 160.43M | -227.64M | -170.79M | -68.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Agenus Inc Stock (AGEN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-04 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2024-07-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-07-18 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2024-07-18 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-06-06 | Iniziato | Robert W. Baird | Outperform |
| 2023-02-28 | Ripresa | H.C. Wainwright | Buy |
| 2022-09-28 | Iniziato | SMBC Nikko | Outperform |
| 2021-12-16 | Iniziato | H.C. Wainwright | Buy |
| 2019-11-19 | Ripresa | B. Riley FBR | Buy |
| 2019-04-22 | Iniziato | B. Riley FBR | Buy |
| 2016-10-28 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2016-10-27 | Reiterato | Maxim Group | Buy |
| 2016-03-11 | Aggiornamento | Maxim Group | Hold → Buy |
| 2015-12-16 | Iniziato | Jefferies | Buy |
| 2015-10-27 | Downgrade | Maxim Group | Buy → Hold |
| 2015-07-27 | Reiterato | MLV & Co | Buy |
| 2015-06-11 | Iniziato | Oppenheimer | Outperform |
| 2015-01-12 | Reiterato | Maxim Group | Buy |
| 2015-01-09 | Reiterato | MLV & Co | Buy |
| 2015-01-09 | Reiterato | Maxim Group | Buy |
| 2014-12-19 | Reiterato | Maxim Group | Buy |
| 2014-05-08 | Reiterato | Maxim Group | Buy |
| 2014-03-14 | Reiterato | MLV & Co | Buy |
| 2013-10-08 | Reiterato | Maxim Group | Buy |
| 2012-01-05 | Iniziato | William Blair | Outperform |
| 2011-12-01 | Iniziato | Global Hunter Securities | Buy |
Mostra tutto
Agenus Inc Borsa (AGEN) Ultime notizie
Aug Summary: Is Agenus Inc stock attractive for income investorsWeekly Risk Report & Stepwise Entry and Exit Trade Signals - moha.gov.vn
Agenus (AGEN) Q4 2024 Earnings Call Transcript - AOL.com
Agenus (AGEN) Q3 2024 Earnings Call Transcript - The Motley Fool
Is Agenus Inc a good long term investmentRSI Overbought/Oversold & Learn the Basics of Investing in 5 Days - earlytimes.in
H.C. Wainwright Upgrades Agenus (AGEN) Stock to Buy - MSN
Short Interest in Agenus Inc. (NASDAQ:AGEN) Rises By 56.5% - MarketBeat
What valuation multiples suggest for Agenus Inc. stockFibonacci Retracement Levels & Free Unlock Hidden Market Opportunities - bollywoodhelpline.com
Agenus publishes C-800-01 trial data in The Journal for Immunotherapy of Cancer - MSN
Agenus Reports Deep, Durable Responses with Botensilimab + Balstilimab in Highly Refractory Ovarian Cancer, Published in JITC - BioSpace
Agenus reports positive results for cancer immunotherapy in ovarian cancer By Investing.com - Investing.com Nigeria
Agenus Inc AJ8 Stock Analysis and ForecastVolume Analysis Techniques & High Return Investment Ideas - earlytimes.in
Botensilimab + Balstilimab in Refractory MSS mCRC: Insights from an ESMO AnalysisAgenus - Oncodaily
Agenus publishes C-800-01 trial data in The Journal for ImmunoTherapy of Cancer - TipRanks
Agenus reports positive results for cancer immunotherapy in ovarian cancer - Investing.com India
Agenus BOT and BAL data faces comparison with standard care - Traders Union
How Agenus Inc. (AJ8) stock behaves under inflation pressureEarnings Risk Report & Stepwise Trade Signal Implementation - Улправда
Can Agenus Inc. stock attract ESG capital inflows2025 Trading Recap & Technical Analysis for Trade Confirmation - ulpravda.ru
Why Agenus Inc. stock is a must watch in 2025IPO Watch & Consistent Income Trade Ideas - Улправда
Aug PreEarnings: How Agenus Inc. (AJ8) stock behaves under inflation pressureJuly 2025 Retail & Step-by-Step Trade Execution Guides - Улправда
Will Agenus Inc. (AJ8) stock benefit from Fed rate cutsEarnings Overview Summary & Low Risk High Win Rate Stock Picks - DonanımHaber
Options Flow: Will Agenus Inc. (AJ8) stock announce a stock split2025 Support & Resistance & Precise Swing Trade Alerts - Улправда
What risks investors should watch in Agenus Inc. stock2025 Major Catalysts & Technical Buy Zone Confirmations - DonanımHaber
Can Agenus Inc. stock reach $100 price targetJuly 2025 Selloffs & Risk Adjusted Buy and Sell Alerts - Улправда
Will Agenus Inc. (AJ8) stock announce a stock splitJuly 2025 Snapshot & Fast Moving Trade Plans - Улправда
What catalysts could drive Agenus Inc. stock higher2025 Trade Ideas & Fast Entry Momentum Alerts - ulpravda.ru
Is Agenus Inc. stock a good choice for value investorsJuly 2025 Catalysts & Short-Term Swing Trade Alerts - Улправда
Breakouts Watch: Is Agenus Inc. stock a good choice for value investorsJuly 2025 Movers & Weekly Momentum Stock Picks - Улправда
AGEN (Agenus) EV-to-OCF : -1.74 (As of Dec. 18, 2025) - GuruFocus
Agenus Inc. (NASDAQ:AGEN) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Agenus (NASDAQ: AGEN) pays CEO Garo Armen 4,316 fully vested shares - Stock Titan
How CTLA-4 Has Re-Emerged as a Central Driver of the Next Immuno-Oncology RevolutionAgenus - Oncodaily
GI Cancer Immunotherapy Breakthroughs Signal New Treatment Era - The Manila Times
BOT/BAL Shows Response in Undifferentiated Pleiomorphic Sarcoma – Agenus - Oncodaily
Is Agenus Inc. (AJ8) stock testing key supportEarnings Miss & Daily Technical Stock Forecast Reports - Newser
Will Agenus Inc. (AJ8) stock sustain bullish trend into 2025Trade Risk Report & Free High Return Stock Watch Alerts - Newser
Agenus accelerates global access with BATTMAN update - Traders Union
Why Agenus Inc. (AJ8) stock fits value portfoliosBull Run & Stock Timing and Entry Methods - Newser
Transcript : Agenus Inc.Shareholder/Analyst Call - MarketScreener
Will Agenus Inc. (AJ8) stock top growth indexesRate Cut & Verified Momentum Stock Ideas - Newser
Agenus (AGEN) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Can Agenus Inc. stock rebound after recent weaknessJuly 2025 Weekly Recap & High Accuracy Investment Signals - Newser
Agenus Inc Stock Analysis and ForecastShort Selling Opportunities & Build Balanced Portfolio - earlytimes.in
What drives Agenus Inc AJ8 stock priceRelative Strength Index (RSI) & Superior Capital Appreciation - earlytimes.in
Free cash flow per share of Agenus Inc. – TRADEGATE:AJ8 - TradingView
Will Agenus Inc. (AJ8) stock outperform energy sector in 2025July 2025 Decliners & Reliable Volume Spike Trade Alerts - newser.com
Candlestick signals on Agenus Inc. stock today2025 Sector Review & Community Consensus Trade Alerts - newser.com
Can Agenus Inc. stock beat analyst upgradesLong Setup & Real-Time Buy Signal Notifications - newser.com
Forecasting Agenus Inc. price range with options dataEarnings Growth Summary & Technical Pattern Based Buy Signals - newser.com
Agenus Inc Azioni (AGEN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.52%
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):